Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy. [electronic resource]
- HIV medicine Feb 2009
- 79-87 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1468-1293
10.1111/j.1468-1293.2008.00661.x doi
Adolescent Adult Aged Anti-Retroviral Agents--adverse effects Biomarkers--metabolism Cardiovascular Diseases--chemically induced Endothelium, Vascular--drug effects Female HIV Infections--drug therapy HIV-1--drug effects Humans Longitudinal Studies Male Middle Aged Predictive Value of Tests RNA, Viral--drug effects Risk Factors Young Adult